Center for Cancer Biology (CCB) (formerly Vesalius Research Center (VRC))


Research facility

Location:
Leuven, Belgium


Publications in cooperation with FAU scientists


Shimelis, H., Mesman, R.L.S., Von Nicolai, C., Ehlen, A., Guidugli, L., Martin, C.,... Couch, F.J. (2017). BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. Cancer Research, 77(11), 2789-2799. https://dx.doi.org/10.1158/0008-5472.CAN-16-2568
Hamdi, Y., Soucy, P., Adoue, V., Michailidou, K., Canisius, S., Lemacon, A.,... Simard, J. (2016). Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. Oncotarget, 7(49), 80140-80163. https://dx.doi.org/10.18632/oncotarget.12818
Zhao, Z., Wen, W., Michailidou, K., Bolla, M.K., Wang, Q., Zhang, B.,... Zheng, W. (2016). Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. Cancer Causes & Control, 27(5), 679-93. https://dx.doi.org/10.1007/s10552-016-0741-6
Thompson, D.J., O'Mara, T.A., Glubb, D.M., Painter, J.N., Cheng, T., Folkerd, E.,... Spurdle, A.B. (2016). CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer. Endocrine-Related Cancer, 23(2), 77-91. https://dx.doi.org/10.1530/ERC-15-0386
Horne, H.N., Chung, C.C., Zhang, H., Yu, K., Prokunina-Olsson, L., Michailidou, K.,... Figueroa, J.D. (2016). Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus. PLoS ONE, 11(8). https://dx.doi.org/10.1371/journal.pone.0160316
Shi, J., Zhang, Y., Zheng, W., Michailidou, K., Ghoussaini, M., Bolla, M.K.,... Long, J. (2016). Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer. International Journal of Cancer, 139(6), 1303-1317. https://dx.doi.org/10.1002/ijc.30150
Darabi, H., Beesley, J., Droit, A., Kar, S., Nord, S., Marjaneh, M.M.,... Dunning, A.M. (2016). Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). Scientific Reports, 6. https://dx.doi.org/10.1038/srep32512
Guo, Y., Andersen, S.W., Shu, X.-O., Michailidou, K., Bolla, M.K., Wang, Q.,... Zheng, W. (2016). Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent. Plos Medicine, 13(8). https://dx.doi.org/10.1371/journal.pmed.1002105
Lei, J., Rudolph, A., Moysich, K.B., Rafiq, S., Behrens, S., Goode, E.L.,... Chang-Claude, J. (2015). Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy. Breast Cancer Research, 17, 18. https://dx.doi.org/10.1186/s13058-015-0522-2
O'Mara, T.A., Glubb, D.M., Painter, J.N., Cheng, T., Dennis, J., Attia, J.,... Spurdle, A.B. (2015). Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer. Endocrine-Related Cancer, 22(5), 851-61. https://dx.doi.org/10.1530/ERC-15-0319
Guo, X., Long, J., Zeng, C., Michailidou, K., Ghoussaini, M., Bolla, M.K.,... Zheng, W. (2015). Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk. Cancer Epidemiology Biomarkers & Prevention, 24(11), 1680-91. https://dx.doi.org/10.1158/1055-9965.EPI-15-0363
Fagerholm, R., Schmidt, M.K., Khan, S., Rafiq, S., Tapper, W., Aittomaki, K.,... Nevanlinna, H. (2015). The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients. Oncotarget, 6(10), 7390-407. https://dx.doi.org/10.18632/oncotarget.3506
Li, J., Lindstroem, L.S., Foo, J.N., Rafiq, S., Schmidt, M.K., Pharoah, P.D.P.,... Czene, K. (2014). 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy. Nature Communications, 5, 4051. https://dx.doi.org/10.1038/ncomms5051

Last updated on 2017-28-01 at 09:14